Do Female BRCA2 Pathogenic Variant Carriers Have an Increased Risk of Lung Cancer?

被引:1
|
作者
Fallet, Vincent [1 ]
Sanchis-Borja, Mateo [1 ]
Benusiglio, Patrick R. [2 ,3 ]
Cadranel, Jacques [4 ]
机构
[1] Sorbonne Univ, Dept Pneumol & Thorac Oncol, Assistance Publ Hop Paris & GRC 4, Tenon Hosp, Paris, France
[2] Grp Hosp Pitie Salpetriere, APHP, Dept Genet, Oncogenet Consulting Oncogenet Funct Unit, Paris, France
[3] Sorbonne Univ, Ctr Rech Saint Antoine, Unite Mixte Rech Sci 938 & SIRIC CURAMUS, INSERM,Equipe Instabilites Microsatellites & Can, Paris, France
[4] Sorbonne Univ, Dept Pneumol & Thorac Oncol, Tenon Hosp, Assistance Publ Hop Paris & GRC 4, Paris, France
关键词
MUTATIONS;
D O I
10.1200/JCO.22.00488
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:2508 / +
页数:2
相关论文
共 50 条
  • [1] Do Female BRCA2 Pathogenic Variant Carriers Have an Increased Risk of Lung Cancer? Reply
    Li, Shuai
    Silvestri, Valentina
    Rebbeck, Timothy R.
    Neuhausen, Susan L.
    Hopper, John L.
    Nielsen, Henriette Roed
    Ottini, Laura
    Antoniou, Antonis C.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (22) : 2509 - +
  • [2] BRCA1 and BRCA2 pathogenic variant carriers and endometrial cancer risk: A cohort study
    Kitson, Sarah J.
    Bafligil, Cemsel
    Ryan, Neil A. J.
    Lalloo, Fiona
    Woodward, Emma R.
    Clayton, Richard D.
    Edmondson, Richard J.
    Bolton, James
    Crosbie, Emma J.
    Evans, D. Gareth
    EUROPEAN JOURNAL OF CANCER, 2020, 136 : 169 - 175
  • [3] Emerging cancer risks in BRCA2 pathogenic germline variant carriers
    Benusiglio, Patrick R.
    Dardenne, Antoine
    Fallet, Vincent
    Cadranel, Jacques
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2023, 31 (12) : 1355 - 1356
  • [4] Emerging cancer risks in BRCA2 pathogenic germline variant carriers
    Patrick R. Benusiglio
    Antoine Dardenne
    Vincent Fallet
    Jacques Cadranel
    European Journal of Human Genetics, 2023, 31 : 1355 - 1356
  • [5] Childhood, adolescent, and young adulthood cancer risk in BRCA1 or BRCA2 pathogenic variant carriers
    Li, Shuai
    Madanat-Harjuoja, Laura
    Leslie, Goska
    Barnes, Daniel R.
    Bolla, Manjeet K.
    Dennis, Joe
    Parsons, Michael T.
    Apostolou, Paraskevi
    Arnold, Norbert
    Bosse, Kristin
    Ahmed, Munaza
    Barwell, Julian
    Brady, Angela
    Brennan, Paul
    Conti, Hector
    Cook, Jackie
    Engel, Christoph
    Evans, D. Gareth
    Fostira, Florentia
    Frone, Megan N.
    Gehrig, Andrea
    Greene, Mark H.
    Hackmann, Karl
    Hahnen, Eric
    Harbeck, Nadia
    Hauke, Jan
    Hentschel, Julia
    Horvath, Judit
    Izatt, Louise
    Kiechle, Marion
    Konstantopoulou, Irene
    Lalloo, Fiona
    Ngeow, Joanne
    Niederacher, Dieter
    Ritter, Julia
    Santamarina, Marta
    Schmutzler, Rita K.
    Searle, Claire
    Sutter, Christian
    Tischkowitz, Marc
    Tripathi, Vishakha
    Vega, Ana
    Wallaschek, Hannah
    Wang-Gohrke, Shan
    Wappenschmidt, Barbara
    Weber, Bernhard H. F.
    Yannoukakos, Drakoulis
    Zhao, Emily
    Easton, Douglas F.
    Antoniou, Antonis C.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2025,
  • [6] INCREASED RISK OF STOMACH-CANCER IN BRCA2 CARRIERS
    CANNONALBRIGHT, LA
    NEUHAUSEN, S
    HIGBEE, M
    SKOLNICK, M
    AMERICAN JOURNAL OF HUMAN GENETICS, 1995, 57 (04) : 320 - 320
  • [7] Copy number variants as modifiers of breast cancer risk for BRCA1/BRCA2 pathogenic variant carriers
    Hakkaart, Christopher
    Pearson, John F.
    Marquart, Louise
    Dennis, Joe
    Wiggins, George A. R.
    Barnes, Daniel R.
    Robinson, Bridget A.
    Mace, Peter D.
    Aittomaki, Kristiina
    Andrulis, Irene L.
    Arun, Banu K.
    Azzollini, Jacopo
    Balmana, Judith
    Barkardottir, Rosa B.
    Belhadj, Sami
    Berger, Lieke
    Blok, Marinus J.
    Boonen, Susanne E.
    Borde, Julika
    Bradbury, Angela R.
    Brunet, Joan
    Buys, Saundra S.
    Caligo, Maria A.
    Campbell, Ian
    Chung, Wendy K.
    Claes, Kathleen B. M.
    Collonge-Rame, Marie-Agnes
    Cook, Jackie
    Cosgrove, Casey
    Couch, Fergus J.
    Daly, Mary B.
    Dandiker, Sita
    Davidson, Rosemarie
    de la Hoya, Miguel
    de Putter, Robin
    Delnatte, Capucine
    Dhawan, Mallika
    Diez, Orland
    Ding, Yuan Chun
    Domchek, Susan M.
    Donaldson, Alan
    Eason, Jacqueline
    Easton, Douglas F.
    Ehrencrona, Hans
    Engel, Christoph
    Evans, D. Gareth
    Faust, Ulrike
    Feliubadalo, Lidia
    Fostira, Florentia
    Friedman, Eitan
    COMMUNICATIONS BIOLOGY, 2022, 5 (01)
  • [8] RE: Childhood, adolescent, and young adulthood cancer risk in BRCA1 or BRCA2 pathogenic variant carriers
    Kratz, Christian P.
    Plon, Sharon E.
    Lupo, Philip J.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2025,
  • [9] Copy number variants as modifiers of breast cancer risk for BRCA1/BRCA2 pathogenic variant carriers
    Christopher Hakkaart
    John F. Pearson
    Louise Marquart
    Joe Dennis
    George A. R. Wiggins
    Daniel R. Barnes
    Bridget A. Robinson
    Peter D. Mace
    Kristiina Aittomäki
    Irene L. Andrulis
    Banu K. Arun
    Jacopo Azzollini
    Judith Balmaña
    Rosa B. Barkardottir
    Sami Belhadj
    Lieke Berger
    Marinus J. Blok
    Susanne E. Boonen
    Julika Borde
    Angela R. Bradbury
    Joan Brunet
    Saundra S. Buys
    Maria A. Caligo
    Ian Campbell
    Wendy K. Chung
    Kathleen B. M. Claes
    Marie-Agnès Collonge-Rame
    Jackie Cook
    Casey Cosgrove
    Fergus J. Couch
    Mary B. Daly
    Sita Dandiker
    Rosemarie Davidson
    Miguel de la Hoya
    Robin de Putter
    Capucine Delnatte
    Mallika Dhawan
    Orland Diez
    Yuan Chun Ding
    Susan M. Domchek
    Alan Donaldson
    Jacqueline Eason
    Douglas F. Easton
    Hans Ehrencrona
    Christoph Engel
    D. Gareth Evans
    Ulrike Faust
    Lidia Feliubadaló
    Florentia Fostira
    Eitan Friedman
    Communications Biology, 5
  • [10] Should unaffected female BRCA2 pathogenic variant carriers be told there is little or no advantage from risk reducing mastectomy?
    Evans, D. Gareth
    Howell, Sacha J.
    Howell, Anthony
    FAMILIAL CANCER, 2019, 18 (04) : 377 - 379